Company intelligence / Profile preview

AngioScore

Fremont, California, United Statesphilips.com.hk ↗

Ownership: Private
Employees: ~33
Development stage: Other

Overview

AngioScore developed and commercialized the AngioSculpt Scoring Balloon Catheter for both coronary and peripheral interventional markets. The uncoated version was FDA-cleared and commercially available. A drug-coated version entered First-in-Human clinical studies targeting coronary in-stent restenosis with endpoints including late lumen loss and major adverse cardiovascular events. Preclinical data showed safety and efficacy in reducing restenosis rates; clinical results were pending as of last public updates.

Therapeutic areas: NephrologyCardiovascular
Modalities: DeviceDrug-coated device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on AngioScore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AngioScore.

Explore the full profile